MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Oversubscribed: Venture & Risk Capital Round_$100m+
Ottimo Pharma
Finance & Acquisition: Ottimo Pharma
Parents
Ottimo Pharma
Children
2024: Former Seagen CEO's biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic
2024: Medicxi participated in series A fundraise along with RTW Investments, Decheng Capital, Janus Henderson Investors, J.P. Morgan Life Sciences Private Capital and Invus. The round was led by OrbiMed, Avoro Capital and Samsara BioCapital
2024: Ottimo raises $140M to compete in chase for new type of cancer drug
Jumps
Key People: Ottimo Pharma
Organization & Developments: Ottimo Pharma